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1. Catch-Up Growth: On What We Know and Why It Matters
Irrespective of presence of growth restriction at birth, preterm infants are vulnerable to extra-uterine
growth restriction (EUGR) during neonatal stay and after discharge, related to cumulative protein and
energy deficits. The nutritional management of preterm neonates—including very low birth weight
(<1500 g) or extremely low birth weight (<1000 g) infants—aims to result in growth patterns that
approximate the intra-uterine fetal growth patterns [1]. If we apply these fetal reference values as
a paradigm, a very relevant portion of these preterm patients still develop EUGR during their
stay at the neonatal intensive care unit (NICU) [2]. This has clinical relevance, since EUGR and
the associated caloric and protein deficits not only result in slower growth velocity, but also are
associated with major neonatal morbidities, including bronchopulmonary dysplasia, retinopathy of
prematurity and impaired neurodevelopment [1,3]. Along the same line, epidemiologic studies have
described additional long-term health consequences of growth restriction and low birth weight, such as
an increased risk of cardiovascular (hypertension, microvasculopathy), renal (acute or chronic renal
impairment) and metabolic morbidities (insulin resistance, liver steatosis) in adult life, covered in
the concept of developmental origins of health and disease (DOHaD) [4]. In term growth-restricted
neonates, accelerated weight gain improves weight and length. However, when occurring after the
first 2 years of life, this is in itself also linked to a higher incidence of cardiovascular diseases in
adulthood [5]. Literature suggests that early catch-up growth (i.e., in the first two years of life) is
likely beneficial with regard to renal and general health, whereas delayed catch-up growth (i.e., after
two years of age) might be harmful [3].
Due to postnatal growth restriction and low birth weight, it is tempting and reasonable to link preterm
birth itself with these long-term health consequences. Moreover, preterms more commonly display these
phenotypic disease characteristics in early adulthood and beyond. The term growth-restricted newborn
may however be an inaccurate model for the preterm infant. In a review of Lapillonne et al., the authors
concluded that in preterm neonates, growth between birth and expected term and 12–18 months post-term
age has no significant effect on later blood pressure and metabolic syndrome, whereas reduced growth
during hospitalization significantly impacts later neurodevelopment [3]. Very recently, and based on
observations on 153 preterm neonates (median weight 1365 g), Embleton et al. largely confirmed this
analysis [6]. The authors documented that the association of rapid weight gain on health is time critical
in preterms: in early infancy, this does not affect metabolic status in adolescence, in contrast to rapid
weight gain in childhood, which should be discouraged: indeed no time to waste [3,6].
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The concept that the growth-restricted term newborn may be an inaccurate model for the preterm
also means that we need to develop clinical research programs to learn more about the most effective
intervention strategies and—as relevant—we should collect data on long-term outcomes and the
mechanisms involved in former preterm neonates. To further illustrate this, it is not unlikely that the
timing of a nutritional optimization intervention matters in preterm neonates and that (side)-effects
may be organ or outcome specific (neuro-development outcomes versus cardiovascular and renal
risks) [3,5,6].
2. Do We Practice What We Know?
Nutritional interventions during and following neonatal stay to improve growth and to avoid
EUGR have been described. As recently summarized, this should be driven by using standardized
feeding protocols with auditing, individualizing nutritional care and monitoring, and using nutritional
support teams during neonatal stay [7]. Similar, post discharge interventions should be evaluated
on their effects, as described in this issue of the journal by Japakasetr et al. [8]. A prospective,
non-randomized interventional cohort study was undertaken to assess the growth of preterm infants
who received a post discharge intervention program and to compare them with preterm infants who
received conventional nutrition services. Intervened infants had significantly greater body weights
(p = 0.013) and head circumferences (p = 0.009) up to 6 months after discharge. Enlistment in a specific
post discharge intervention program at home thus resulted in significantly reduced post-discharge
growth restriction in very low birth weight preterm infants [8].
Unfortunately, we still fail to implement these strategies sufficiently, as recently highlighted in
a French survey [9]. Using a questionnaire on 276 preterm (30–33 weeks gestational age) neonates
hospitalized in 29 different NICUs, the authors documented that there was divergence between the
intended and the actual practice for both protein and lipid intake. Weight Z-score decreased from
birth (−0.17 ± 0.88) to term equivalent age (−1.00 ± 0.82), and the EUGR rate at term age was 24.2%.
The authors concluded that nutritional support was not in compliance with recommendations and that
the rate of EUGR remained relevant. Efforts are needed to improve adherence to nutrition guidelines
and growth outcomes: implementation remains a major hurdle [9]: no time to waste.
3. Implementation Strategies and Long-Term Outcome Studies Are Needed
Effective implementation necessitates the simultaneous application of standardized recommendations
to initiate, advance, and fortify enteral feedings, and timely discontinue the use of central lines.
Such a multifactorial strategy can be achieved through the quality improvement concept of ‘care bundle’.
Care bundle approaches in NICUs have been reported to reduce catheter-related sepsis, retinopathy of
prematurity or to improve neonatal pain management [10]. Very recently, such a ‘care bundle’ strategy to
adhere to a nutrition protocol has also been described as a very effective approach for improving linear
and head circumference growth, reducing postnatal growth restriction, and decreasing comorbidities
(necrotizing enterocolitis, sepsis) in very low birth weight (<1500 g) infants [11].
Besides research on implementation, we strongly recommend the collection and analysis of
long-term outcome data in former preterm neonates, linked to nutritional strategies and growth
parameters. Such databases should not be limited to neuro-cognitive and behavioral outcomes, but
should also include data on cardiovascular, renal and metabolic outcome variables. Linking such
datasets with perinatal characteristics and growth patterns should instruct us how to further time,
subdivide or individualize nutritional care in this specific population. Such a research agenda
will necessitate the validation of biomarkers and tools (e.g., retinal imaging, carotid intima-media
thickness, advanced renal function assessment, biomarkers or metabolic syndrome) currently used in
long-term follow-up studies in adults to infants, children and adolescents. Fortunately, there are recent
efforts that illustrate the feasibility of such research programs in former preterm neonates and these
efforts are crucial to further improve knowledge driven practices and understanding the underlying
mechanisms [6,7,12,13].
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In conclusion, early nutritional management in preterm neonates is feasible during and following
neonatal stay to avoid or treat growth restriction and its consequences. Further studies should
focus on implementation strategies, while long-term outcome studies are urgently needed to link
perinatal nutritional practices to long-term neurodevelopmental outcomes, as well as other aspects of
healthy aging.
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